TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE vs TRANDOLAPRIL TABLETS

Compare TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE (Trandolapril and Verapamil Hydrochloride) and TRANDOLAPRIL TABLETS (Trandolapril) — clinical data, side effects, and patient experiences.

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

Trandolapril and Verapamil Hydrochloride · ACE Inhibitor

How it works

ACE Inhibitor agent

Approved for

consideration should be given to the fact that an angiotensin converting enzyme inhibitor

captopril

has caused agranulocytosis

particularly in patients with renal impairment or collagen vascular disease

OralTablet

TRANDOLAPRIL TABLETS

Trandolapril · ACE Inhibitor

How it works

ACE Inhibitor agent

Approved for

See full prescribing information

OralTablet

Quick Comparison

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDETRANDOLAPRIL TABLETS

Drug Class

ACE Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

Shortness of Breath

1-10%

Fatigue

1-10%

Dizziness

1-10%

Diarrhea

1-10%

Weakness

1-10%

Cough

1-10%

Drug Not Working

1-10%

Nausea

1-10%

TRANDOLAPRIL TABLETS

Shortness of Breath

1-10%

Fatigue

1-10%

Dizziness

1-10%

Diarrhea

1-10%

Weakness

1-10%

Cough

1-10%

Drug Not Working

1-10%

Nausea

1-10%

FDA Warnings

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

WARNING: FETAL TOXICITY • When pregnancy is detected, discontinue trandolapril and verapamil hydrochloride extended-release tablets as soon as possible
• Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (see WARNINGS: Fetal Toxicity )

TRANDOLAPRIL TABLETS

WARNING: FETAL TOXICITY When pregnancy is detected, discontinue trandolapril as soon as possible
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (See WARNINGS: Fetal Toxicity )

Clinical Trial Data

No head-to-head clinical studies found for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE vs TRANDOLAPRIL TABLETS.

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE vs TRANDOLAPRIL TABLETS: What You Should Know

Key Differences

Both TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE and TRANDOLAPRIL TABLETS belong to the ACE Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE carries 2 FDA warnings. TRANDOLAPRIL TABLETS carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Lisinopril vs TRANDOLAPRIL TABLETS→Lisinopril vs TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE→TRANDOLAPRIL vs TRANDOLAPRIL TABLETS→TRANDOLAPRIL vs TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE→RAMIPRIL vs TRANDOLAPRIL TABLETS→RAMIPRIL vs TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE→

Loading comparison data...

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE vs TRANDOLAPRIL TABLETS

Compare TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE (Trandolapril and Verapamil Hydrochloride) and TRANDOLAPRIL TABLETS (Trandolapril) — clinical data, side effects, and patient experiences.

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

Trandolapril and Verapamil Hydrochloride · ACE Inhibitor

How it works

ACE Inhibitor agent

Approved for

consideration should be given to the fact that an angiotensin converting enzyme inhibitor

captopril

has caused agranulocytosis

particularly in patients with renal impairment or collagen vascular disease

OralTablet

TRANDOLAPRIL TABLETS

Trandolapril · ACE Inhibitor

How it works

ACE Inhibitor agent

Approved for

See full prescribing information

OralTablet

Quick Comparison

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDETRANDOLAPRIL TABLETS

Drug Class

ACE Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

Shortness of Breath

1-10%

Fatigue

1-10%

Dizziness

1-10%

Diarrhea

1-10%

Weakness

1-10%

Cough

1-10%

Drug Not Working

1-10%

Nausea

1-10%

TRANDOLAPRIL TABLETS

Shortness of Breath

1-10%

Fatigue

1-10%

Dizziness

1-10%

Diarrhea

1-10%

Weakness

1-10%

Cough

1-10%

Drug Not Working

1-10%

Nausea

1-10%

FDA Warnings

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

WARNING: FETAL TOXICITY • When pregnancy is detected, discontinue trandolapril and verapamil hydrochloride extended-release tablets as soon as possible
• Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (see WARNINGS: Fetal Toxicity )

TRANDOLAPRIL TABLETS

WARNING: FETAL TOXICITY When pregnancy is detected, discontinue trandolapril as soon as possible
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (See WARNINGS: Fetal Toxicity )

Clinical Trial Data

No head-to-head clinical studies found for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE vs TRANDOLAPRIL TABLETS.

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE vs TRANDOLAPRIL TABLETS: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.